Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Shares Issued (2018 - 2025)

Cue Biopharma (CUE) has disclosed Shares Issued for 7 consecutive years, with $10.2 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 128137.5% to $10.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.1 million through Dec 2025, up 94.73% year-over-year, with the annual reading at $28.3 million for FY2025, 161.62% up from the prior year.
  • Shares Issued hit $10.2 million in Q4 2025 for Cue Biopharma, up from -$8000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $10.8 million in Q3 2024 to a low of -$2.1 million in Q4 2021.
  • Historically, Shares Issued has averaged $2.1 million across 4 years, with a median of $348500.0 in 2021.
  • Biggest five-year swings in Shares Issued: plummeted 70.4% in 2021 and later surged 128137.5% in 2025.
  • Year by year, Shares Issued stood at -$2.1 million in 2021, then skyrocketed by 77.05% to -$473000.0 in 2023, then surged by 98.31% to -$8000.0 in 2024, then soared by 128137.5% to $10.2 million in 2025.
  • Business Quant data shows Shares Issued for CUE at $10.2 million in Q4 2025, -$8000.0 in Q4 2024, and $10.8 million in Q3 2024.